Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Let's talk, oscar
15
Jul 28, 2010 11:45AM

Jul 28, 2010 11:48AM
10
Jul 28, 2010 12:12PM
5
Jul 28, 2010 12:28PM
6
Jul 28, 2010 12:30PM
2
Jul 28, 2010 12:32PM
11
Jul 28, 2010 12:38PM
6
Jul 28, 2010 12:39PM
6
Jul 28, 2010 12:42PM
5
Jul 28, 2010 12:53PM
5
Jul 28, 2010 12:57PM
2
Jul 28, 2010 12:59PM
4
Jul 28, 2010 01:05PM
4
Jul 28, 2010 01:06PM

PDSG has to be the way forward as licensing revenues will eventually dry up.

Indeed, paying dividends will push the price up, but logic dictates that any sustained gain must be supported by increasing revenues, not a decreasing infringer pool.

CDX4 has to be developed further to meet demand from other markets, for example read:

http://www.computerweekly.com/Articles/2010/06/03/241059/How-to-improve-productivity-through-effective-information-sharing-and-collaboration.htm

Going forward, by all means pay dividends and hold a cash reserve, but serious consideration must be given to investing license fee proceeds to ensure benefits for both the short and long term investor, including further M&A activities based on the lessons learnt from prior forays into the area.

.

.

.

Be well

9
Jul 28, 2010 01:31PM
3
Jul 28, 2010 02:00PM
3
Jul 28, 2010 02:12PM
6
Jul 28, 2010 04:16PM
7
Jul 28, 2010 05:56PM
8
Jul 28, 2010 07:33PM
18
Jul 28, 2010 08:07PM
5
Jul 28, 2010 10:06PM
Share
New Message
Please login to post a reply